World's Best Scientists 2026 revealed!
Judilyn Fuentes-Duculan

Judilyn Fuentes-Duculan

D-Index & Metrics

Immunology

D-Index
56
Citations
15821
World Ranking
3679
National Ranking
1695

Judilyn Fuentes-Duculan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Judilyn Fuentes-Duculan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 99 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Judilyn Fuentes-Duculan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Judilyn Fuentes-Duculan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Judilyn Fuentes-Duculan is affiliated with Rockefeller University in the United States. Their research primarily spans the fields of medicine and immunology and microbiology, with a focused contribution to dermatology as a key subfield. Their scientific work covers several areas including dermatology and skin diseases, psoriasis treatment and pathogenesis, cytokine signaling pathways and interactions, and urticaria and related conditions.

Their recent publications illustrate a strong orientation towards understanding and treating inflammatory and immunological skin conditions. Notable papers include:

  • Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis (2020, Journal of Investigative Dermatology)
  • The erythema Q-score, an imaging biomarker for redness in skin inflammation (2020, Experimental Dermatology)
  • Barzolvolimab Improves Urticaria Control and Quality of Life in Patients with Chronic Spontaneous Urticaria: 52-Week Data (2025, Journal of Allergy and Clinical Immunology)
  • Cover Image (2021, Experimental Dermatology)
  • Treatment with Barzolvolimab Improves Urticaria Control and Quality of Life in Patients with Chronic Inducible Urticaria: Phase 2 12 Week Results (2025, Journal of Allergy and Clinical Immunology)

Fuentes-Duculan frequently collaborates with colleagues in their field. Frequent co-authors include Mayte Suárez-Fariñas, James G. Krueger, Sandra Garcet, John W. Frew, and Lauren R. Penzi.

The scientist's work is published across several journals known for dermatological and immunological research, such as Experimental Dermatology, Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology, and Advances in Therapy.

Their research subfields include:

  • Dermatology
  • Immunology
  • Oncology
  • Rheumatology
  • Pathology and Forensic Medicine

Main research topics covered are:

  • Dermatology and Skin Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Cytokine Signaling Pathways and Interactions
  • Urticaria and Related Conditions
  • Acne and Rosacea Treatments and Effects
  • Mast cells and histamine
  • Autoimmune Bullous Skin Diseases

Best Publications

  • Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

    Michelle A. Lowes;Toyoko Kikuchi;Judilyn Fuentes-Duculan;Irma Cardinale

  • Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.

    Julia K. Gittler;Julia K. Gittler;Avner Shemer;Mayte Suárez-Fariñas;Judilyn Fuentes-Duculan

  • Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

    K.E. Nograles;L.C. Zaba;E. Guttman-Yassky;J. Fuentes-Duculan

  • Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.

    Lisa C. Zaba;Irma Cardinale;Patricia Gilleaudeau;Mary Sullivan-Whalen

  • IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells

    Kristine E. Nograles;Lisa C. Zaba;Avner Shemer;Judilyn Fuentes-Duculan

  • Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

    Michelle A. Lowes;Francesca Chamian;Maria Veronica Abello;Judilyn Fuentes-Duculan

  • Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell polarizing myeloid dendritic cells

    Lisa C. Zaba;Judilyn Fuentes-Duculan;Narat John Eungdamrong;Maria Veronica Abello

  • Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin.

    Hitokazu Esaki;Hitokazu Esaki;Patrick M. Brunner;Yael Renert-Yuval;Tali Czarnowicki

  • Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis

    Emma Guttman-Yassky;Michelle A. Lowes;Judilyn Fuentes-Duculan;Lisa C. Zaba

  • Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.

    Emma Guttman-Yassky;Emma Guttman-Yassky;Patrick M. Brunner;Avidan U. Neumann;Avidan U. Neumann;Avidan U. Neumann;Saakshi Khattri

  • Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages

    Lisa C. Zaba;Judilyn Fuentes-Duculan;Ralph M. Steinman;James G. Krueger

  • A subpopulation of CD163-positive macrophages is classically activated in psoriasis.

    Judilyn Fuentes-Duculan;Mayte Suárez-Fariñas;Lisa C. Zaba;Kristine E. Nograles

  • Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not “immediate-response” TNF genes

    Lisa C. Zaba;Mayte Suárez-Fariñas;Judilyn Fuentes-Duculan;Kristine E. Nograles

  • Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis

    Mayte Suárez-Fariñas;Katherine Li;Judilyn Fuentes-Duculan;Karen Hayden

  • Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis

    Emma Guttman-Yassky;Emma Guttman-Yassky;Mayte Suárez-Fariñas;Andrea Chiricozzi;Andrea Chiricozzi;Kristine E. Nograles

  • Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis

    Emma Guttman-Yassky;Michelle A. Lowes;Judilyn Fuentes-Duculan;Julia Whynot

  • Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response

    Nikhil Dhingra;Nikhil Dhingra;Avner Shemer;Joel Correa da Rosa;Mariya Rozenblit;Mariya Rozenblit

  • Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.

    Mayte Suárez-Fariñas;Benjamin Ungar;Shinji Noda;Anjali Shroff

  • Resolved psoriasis lesions retain expression of a subset of disease-related genes

    Mayte Suárez-Fariñas;Judilyn Fuentes-Duculan;Michelle A. Lowes;James G. Krueger

  • Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated.

    Julia S. Pettersen;Judilyn Fuentes-Duculan;Mayte Suárez-Fariñas;Katherine C. Pierson

  • A Novel Chimeric Lysin Shows Superiority to Mupirocin for Skin Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus Strains

    Mina Pastagia;Chad Euler;Peter Chahales;Judilyn Fuentes-Duculan

  • Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.

    Saakshi Khattri;Saakshi Khattri;Patrick M. Brunner;Sandra Garcet;Robert Finney

Frequent Co-Authors

James G. Krueger
James G. Krueger Rockefeller University
Mayte Suárez-Fariñas
Mayte Suárez-Fariñas Icahn School of Medicine at Mount Sinai
Emma Guttman-Yassky
Emma Guttman-Yassky Icahn School of Medicine at Mount Sinai
Michelle A. Lowes
Michelle A. Lowes Rockefeller University
Arne N. Akbar
Arne N. Akbar University College London
Mark Lebwohl
Mark Lebwohl Icahn School of Medicine at Mount Sinai
Francisco J. Quintana
Francisco J. Quintana Harvard Medical School
Nigel Klein
Nigel Klein University College London
John Greenwood
John Greenwood University College London
Vincent A. Fischetti
Vincent A. Fischetti Rockefeller University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden your career possibilities. Nursing programs often overlap with immunological knowledge, offering practical experience in patient care and immune-related conditions.

Many students opt for the easiest ABSN programs to get into, which provide an accelerated route to becoming a registered nurse. These programs are designed for candidates with non-nursing backgrounds seeking to enter the nursing field quickly.

Alternatively, pursuing the fastest and easiest LPN programs can offer entry-level clinical experience. Licensed Practical Nurses play a vital role in supporting complex immunology treatments under the supervision of registered nurses and doctors.

For advanced clinical careers, the easiest NP programs to get into enable nurses to specialize further, often including immunology-related specialties.

Specifically, mental health intersects with immunology in several emerging research areas. The best online psychiatric mental health nurse practitioner programs provide training to address psychiatric conditions with potential immune system links, enhancing holistic patient care.

Best Scientists Citing Judilyn Fuentes-Duculan

Trending Scientists

Recently Published Articles